Literature DB >> 7609550

Recombinant hirudin as a new anticoagulant during cardiac operations instead of heparin: successful for aortic valve replacement in man.

F C Riess1, C Löwer, C Seelig, N Bleese, J Kormann, G Müller-Berghaus, B Pötzsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7609550     DOI： 10.1016/S0022-5223(05)80033-9

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  7 in total

Review 1.  Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.

Authors:  N Lubenow; A Greinacher
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

Review 2.  Laboratory diagnosis of heparin-induced thrombocytopenia and monitoring of alternative anticoagulants.

Authors:  Albrecht Leo; Susanne Winteroll
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

Review 3.  New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin.

Authors:  Shannon M Bates; Jeffrey I Weitz
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

4.  The emergency use of recombinant hirudin in cardiopulmonary bypass. 1999.

Authors:  Nicklett Johnston; Michael E Jessen; Michael DiMaio; Debra S Douglass
Journal:  J Extra Corpor Technol       Date:  2005-09

Review 5.  Hirudin-based anticoagulant strategies for patients with suspected heparin-induced thrombocytopenia undergoing percutaneous coronary interventions and bypass grafting.

Authors:  R C Becker
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

Review 6.  New anticoagulant drugs.

Authors:  J I Weitz
Journal:  J Thromb Thrombolysis       Date:  2001-09       Impact factor: 2.300

Review 7.  Benefit-risk assessment of treatments for heparin-induced thrombocytopenia.

Authors:  Harry Messmore; Walter Jeske; William Wehrmacher; Jeanine Walenga
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.